427 related articles for article (PubMed ID: 6777774)
1. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.
Sawyer TK; Sanfilippo PJ; Hruby VJ; Engel MH; Heward CB; Burnett JB; Hadley ME
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5754-8. PubMed ID: 6777774
[TBL] [Abstract][Full Text] [Related]
2. Prolonged stimulation of S91 melanoma tyrosinase by [Nle4, D-Phe7]-substituted alpha-melanotropins.
Abdel Malek ZA; Kreutzfeld KL; Marwan MM; Hadley ME; Hruby VJ; Wilkes BC
Cancer Res; 1985 Oct; 45(10):4735-40. PubMed ID: 2992767
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological actions of highly potent and prolonged acting biotin-labeled melanotropins.
Chaturvedi DN; Knittel JJ; Hruby VJ; Castrucci AM; Hadley ME
J Med Chem; 1984 Nov; 27(11):1406-10. PubMed ID: 6436488
[TBL] [Abstract][Full Text] [Related]
4. Potent and prolonged melanotropic activities of the alpha-MSH fragment analog, Ac-[Nle4,D-Phe7]-alpha-MSH4-9-NH2.
Klemes DG; Kreutzfeld KL; Hadley ME; Cody WL; Hruby VJ
Biochem Biophys Res Commun; 1986 Jun; 137(2):722-8. PubMed ID: 3089218
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of the superagonist [N alpha-chlorotriazinylaminofluorescein-Ser1,Nle4,D-Phe7]-al pha-MSH.
Chaturvedi DN; Hruby VJ; Castrucci AM; Kreutzfeld KL; Hadley ME
J Pharm Sci; 1985 Mar; 74(3):237-40. PubMed ID: 2989482
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-function studies of melanocyte stimulating hormone analogues modified in the 2 and 4(7) positions: comparison of activities on frog skin melanophores and melanoma adenylate cyclase.
Hruby VJ; Sawyer TK; Yang YC; Bregman MD; Hadley ME; Heward CB
J Med Chem; 1980 Dec; 23(12):1432-7. PubMed ID: 7452698
[TBL] [Abstract][Full Text] [Related]
7. [Nle4, D-Phe7]-alpha-MSH: a superpotent melanotropin that "irreversibly" activates melanoma tyrosinase.
Hadley ME; Abdel Malek ZA; Marwan MM; Kreutzfeld KL; Hruby VJ
Endocr Res; 1985; 11(3-4):157-70. PubMed ID: 3009169
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of S91 melanoma tyrosinase activity by superpotent alpha-melanotropins.
Marwan MM; Abdel Malek ZA; Kreutzfeld KL; Hadley ME; Wilkes BC; Hruby VJ; Castrucci AM
Mol Cell Endocrinol; 1985 Jul; 41(2-3):171-7. PubMed ID: 3926559
[TBL] [Abstract][Full Text] [Related]
9. [half-Cys4,half-Cys10]-alpha-Melanocyte-stimulating hormone: a cyclic alpha-melanotropin exhibiting superagonist biological activity.
Sawyer TK; Hruby VJ; Darman PS; Hadley ME
Proc Natl Acad Sci U S A; 1982 Mar; 79(6):1751-5. PubMed ID: 6281785
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of tritium labeled Ac-[Nle4, D-Phe7]-alpha-MSH4-11-NH2: a superpotent melanotropin with prolonged biological activity.
Wilkes BC; Hruby VJ; Yamamura HI; Akiyama K; Castrucci AM; Hadley ME; Andrews JR; Wan YP
Life Sci; 1984 Mar; 34(10):977-84. PubMed ID: 6608041
[TBL] [Abstract][Full Text] [Related]
11. Behavioral effects of [4-norleucine, 7-D-phenylalanine]-alpha-melanocyte-stimulating hormone.
Kobobun K; O'Donohue TL; Handelmann GE; Sawyer TK; Hruby VJ; Hadley ME
Peptides; 1983; 4(5):721-4. PubMed ID: 6657517
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and actions of a melanotropin conjugate, Ac-[Nle4, Glu(gamma-4'-hydroxyanilide)5, D-Phe7]alpha-MSH4-10-NH2, on melanocytes and melanoma cells in vitro.
al-Obeidi F; Mulcahy M; Pitt VS; Begay V; Hadley ME; Hruby VJ
J Pharm Sci; 1990 Jun; 79(6):500-4. PubMed ID: 2168479
[TBL] [Abstract][Full Text] [Related]
13. Calcium-dependent prolonged effects on melanophores of [4-norleucine, 7-D-phenylalanine]-alpha-melanotropin.
Hadley ME; Anderson B; Heward CB; Sawyer TK; Hruby VJ
Science; 1981 Aug; 213(4511):1025-7. PubMed ID: 6973820
[TBL] [Abstract][Full Text] [Related]
14. Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics.
Al-Obeidi F; Castrucci AM; Hadley ME; Hruby VJ
J Med Chem; 1989 Dec; 32(12):2555-61. PubMed ID: 2555512
[TBL] [Abstract][Full Text] [Related]
15. Biological activity, binding, and metabolic fate of Ac-[Nle4, D-Phe7]alpha-MSH4-11NH2 with the F1 variant of B16 melanoma cells.
Panasci LC; McQuillan A; Kaufman M
J Cell Physiol; 1987 Jul; 132(1):97-103. PubMed ID: 3110178
[TBL] [Abstract][Full Text] [Related]
16. Design of potent linear alpha-melanotropin 4-10 analogues modified in positions 5 and 10.
Al-Obeidi F; Hruby VJ; Castrucci AM; Hadley ME
J Med Chem; 1989 Jan; 32(1):174-9. PubMed ID: 2535874
[TBL] [Abstract][Full Text] [Related]
17. The melanotropic peptide, [Nle4,D-Phe7] alpha-MSH, stimulates human melanoma tyrosinase activity and inhibits cell proliferation.
Jiang J; Sharma SD; Nakamura S; Lai JY; Fink JL; Hruby VJ; Hadley ME
Pigment Cell Res; 1995 Dec; 8(6):314-23. PubMed ID: 8789740
[TBL] [Abstract][Full Text] [Related]
18. Fluorine-18-labeled [Nle4,D-Phe7]-alpha-MSH, an alpha-melanocyte stimulating hormone analogue.
Vaidyanathan G; Zalutsky MR
Nucl Med Biol; 1997 Feb; 24(2):171-8. PubMed ID: 9089709
[TBL] [Abstract][Full Text] [Related]
19. Racemization effects on melanocyte-stimulating hormones and related peptides.
Bool AM; Gray GH; Hadley ME; Heward CB; Hruby VJ; Sawyer TK; Yang YC
J Endocrinol; 1981 Jan; 88(1):57-65. PubMed ID: 6970245
[TBL] [Abstract][Full Text] [Related]
20. [Nle4, D-Phe7]-alpha-MSH: a superpotent melanotropin with prolonged action on vertebrate chromatophores.
Hadley ME; Mieyr JH; Martin BE; Castrucci AM; Hruby VJ; Sawyer TK; Powers EA; Rao KR
Comp Biochem Physiol A Comp Physiol; 1985; 81(1):1-6. PubMed ID: 2859941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
